false
Catalog
2022 AOSSM Annual Meeting Recordings with CME
Outcomes of Percutaneous Barbotage for Calcific Te ...
Outcomes of Percutaneous Barbotage for Calcific Tendonitis of the Shoulder
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
on outcomes of percutaneous barbiturates for calcific tendonitis of the shoulder. Note exclosures, this research was done at my fellowship at Hoag Orthopedic Institute. So the background, calcific tendonitis, painful shoulder condition that can cause acute disabilitating pain in patients, secondary deposition and resorption of calcium deposits within the rotator cuff tendon. So the workup, we typically start with the history with the sudden pain of insidious onset, extreme pain that can even bring patients to the ER or urgent care, X-ray and then MRI if there's concern for concomitant rotator cuff pathology. So here's an X-ray showing that nice chunk of calcium in the supraspinatus. So the treatment options, we've always started with oral anti-inflammatories, steroid injection, either oral or subacromial. And then there's been talks of extracorporeal shockwave, the needle barbiturates and ultimately surgical decompression with or without a rotator cuff repair. So the methods for our study, all patients were seen and treated at a single center. They were first evaluated by a fellowship trained orthopedic sports medicine surgeon or shoulder elbow surgeon. And then a single fellowship trained primary care sports medicine performed the procedure. So for the procedure, the calcium deposit was identified under ultrasound. The skin at the site of entry in the subacromial space were anesthetized using 10 cc's of 1% and an 18 gauge needle was inserted into the calcium deposit under the ultrasound, aspirated and then ultimately steroids injected. So this is that same patient, you can see the calcium deposit on the X-ray and this is afterwards, immediately after the procedure, it's completely gone. So results, since 2018, 22 patients had undergone the procedure, 19 opted in. About 73% were female, 27 male. The majority of the patients also had at least one significant medical comorbidity and the average age being 56 with quite a wide range of 31 to 76 years old. So the average follow-up time was around one year after this and then the SANE score for the affected extremity was 81 while the unaffected was 91. This approached significance but didn't quite make it. I think the big takeaway from this is of all 19 patients that underwent this, not a single one ended up going into surgery in the prospective follow-up time. So conclusion, the needle barbatage is a safe and effective way to treat calcific tendonitis that may prevent the surgical treatment for it. Alright, thanks guys.
Video Summary
In the video, the speaker discusses the use of percutaneous barbiturates for the treatment of calcific tendonitis of the shoulder. The condition is characterized by the deposition and resorption of calcium deposits in the rotator cuff tendon, causing severe pain and disability. The speaker explains the typical workup, which includes a history evaluation, X-ray, and MRI if needed. Treatment options range from anti-inflammatories to surgical decompression. The study conducted at the Hoag Orthopedic Institute involved 19 patients who underwent the procedure. The results showed that none of the patients required surgery during the follow-up period, suggesting that needle barbiturates can effectively treat calcific tendonitis and potentially prevent the need for surgical intervention.
Asset Caption
Troy Shields, MD
Keywords
video
percutaneous barbiturates
calcific tendonitis
shoulder
treatment
×
Please select your language
1
English